Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 3, 2010, Pages

  Gao, Lie ^a   Li, Yulong ^a   Schultz, Harold D ^a   Wang, Wei Zhong ^a   Wang, Wei ^a   Finch, Marcus ^a   Smith, Lynette M ^b   Zucker, Irving H ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; K+ channel; p38 mitogenactivated protein kinase; Reactive oxygen species

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 AMINOPYRIDINE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; KV4.3 PROTEIN; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; SHAL POTASSIUM CHANNEL; TEMPOL; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EXCITATION; GENE EXPRESSION; GENETIC SCREENING; GENOME; HEART FAILURE; HYPERTENSION; MALE; MEDULLA OBLONGATA; MICROINJECTION; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL MEMBRANE CONDUCTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REAL TIME POLYMERASE CHAIN REACTION; ROSTRAL VENTROLATERAL MEDULLA; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; BODY WEIGHT; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HEART FAILURE; HEMODYNAMICS; MALE; MEDULLA OBLONGATA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; SHAL POTASSIUM CHANNELS; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

EID: 77749291836     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00145.2009     Document Type: Article

References (49)

1. Belugin S, Mifflin S. Transient voltage-dependent potassium currents are reduced in NTS neurons isolated from renal wrap hypertensive rats. J Neurophysiol 94: 3849-3859, 2005.
2. Bundey RA, Jones PG, Kendall DA. An investigation of noradrenaline uptake and release by the CATH.a cell line. J Neurochem 74: 799-806, 2000.
3. Chida K, Miyagawa M, Kawamura H, Takasu T. Effects of chemical stimulation of the rostral ventrolateral medulla on cerebral and renal microcirculation in spontaneously hypertensive rats. J Auton Nerv Syst 70: 51-55, 1998.
4. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823, 1984.
5. Connor JA, Stevens CF. Prediction of repetitive firing behaviour from voltage clamp data on an isolated neurone soma. J Physiol 213: 31-53, 1971.
6. Dampney RA, Fontes MA, Hirooka Y, Horiuchi J, Potts PD, Tagawa T. Role of angiotensin II receptors in the regulation of vasomotor neurons in the ventrolateral medulla. Clin Exp Pharmacol Physiol 29: 467-472, 2002.
7. Dampney RA, Horiuchi J, Tagawa T, Fontes MA, Potts PD, Polson JW. Medullary and supramedullary mechanisms regulating sympathetic vasomotor tone. Acta Physiol Scand 177: 209-218, 2003.
8. DiBona GF, Jones SY, Brooks VL. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Integr Comp Physiol 269: R1189-R1196, 1995.
9. Du JQ, Sun CW, Tang JS. Effect of angiotensin II type 1 receptor on delayed rectifier potassium current in catecholaminergic CATH.a cells. Acta Pharmacol Sin 25: 1145-1150, 2004.
10. Francis GS. Neurohumoral mechanisms involved in congestive heart failure. Am J Cardiol 55: 15A-21A, 1985.
11. Gao L, Schultz HD, Patel KP, Zucker IH, Wang W. Augmented input from cardiac sympathetic afferents inhibits baroreflex in rats with heart failure. Hypertension 45: 1173-1181, 2005.
12. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Superoxide mediates sympathoexcitation in heart failure: roles of angiotensin II and NAD(P)H oxidase. Circ Res 95: 937-944, 2004.
13. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol 288: H2271-H2279, 2005.
14. Gao L, Wang WZ, Wang W, Zucker IH. Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure. Hypertension 52: 708-714, 2008.
15. Getting PA. Mechanisms of pattern generation underlying swimming in Tritonia. III. Intrinsic and synaptic mechanisms for delayed excitation. J Neurophysiol 49: 1036-1050, 1983.
16. Just H. Peripheral adaptations in congestive heart failure: a review. Am J Med 90: 23S-26S, 1991.
17. Kaab S, Dixon J, Duc J, Ashen D, Nabauer M, Beuckelmann DJ, Steinbeck G, McKinnon D, Tomaselli GF. Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 98: 1383-1393, 1998.
18. Kapoor V, Minson J, Chalmers J. Ventral medulla stimulation increases blood pressure and spinal cord amino acid release. Neuroreport 3: 55-58, 1992.
19. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 26: 1257-1263, 1995.
20. Lazaroff M, Dunlap K, Chikaraishi DM. A CNS catecholaminergic cell line expresses voltage-gated currents. J Membr Biol 151: 279-291, 1996.
21. Lee JK, Nishiyama A, Kambe F, Seo H, Takeuchi S, Kamiya K, Kodama I, Toyama J. Downregulation of voltage-gated K+ channels in rat heart with right ventricular hypertrophy. Am J Physiol Heart Circ Physiol 277: H1725-H1731, 1999.
22. + channel gene transcription and protein expression in pituitary cells. J Biol Chem 270: 6036-6041, 1995.
23. + channel gene expression in differentiated cells. J Neurobiol 37: 60-68, 1998.
24. Liu JL, Irvine S, Reid IA, Patel KP, Zucker IH. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure. A role for angiotensin II. Circulation 102: 1854-1862, 2000.
25. Llinas RR. The intrinsic electrophysiological properties of mammalian neurons: insights into central nervous system function. Science 242: 1654-1664, 1988.
26. Moreira TH, Cruz JS, Weinreich D. Angiotensin II increases excitability and inhibits a transient potassium current in vagal primary sensory neurons. Neuropeptides 43: 193-199, 2009.
27. + channel diversity in the mammalian myocardium. J Physiol 525: 285-298, 2000.
28. Palkovits M, Brownstein MJ. Maps and Guide to Microdissection of the Rat Brain. New York: Elsevier, 1988.
29. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic, 1997.
30. Rudy B. Diversity and ubiquity of K channels. Neuroscience 25: 729-749, 1988.
31. Sanguinetti MC, Johnson JH, Hammerland LG, Kelbaugh PR, Volkmann RA, Saccomano NA, Mueller AL. Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. Mol Pharmacol 51: 491-498, 1997.
32. Serodio P, Kentros C, Rudy B. Identification of molecular components of A-type channels activating at subthreshold potentials. J Neurophysiol 72: 1516-1529, 1994.
33. + (A-type) currents in rat brain. J Neurophysiol 79: 1081-1091, 1998.
34. + channels operating at subthreshold potentials with unique expression in heart and brain. J Neurophysiol 75: 2174-2179, 1996.
35. Sonner PM, Filosa JA, Stern JE. Diminished A-type potassium current and altered firing properties in presympathetic PVN neurones in renovascular hypertensive rats. J Physiol 586: 1605-1622, 2008.
36. Sonner PM, Stern JE. Functional role of A-type potassium currents in rat presympathetic PVN neurones. J Physiol 582: 1219-1238, 2007.
37. Sun C, Du J, Raizada MK, Sumners C. Modulation of delayed rectifier potassium current by angiotensin II in CATH.a cells. Biochem Biophys Res Commun 310: 710-714, 2003.
38. Suri C, Fung BP, Tischler AS, Chikaraishi DM. Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J Neurosci 13: 1280-1291, 1993.
39. + channel gene transcription and expression in clonal pituitary cells. Neuron 11: 359-369, 1993.
40. Takimoto K, Li D, Hershman KM, Li P, Jackson EK, Levitan ES. Decreased expression of Kv4.2 and novel Kv43 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats. Circ Res 81: 533-539, 1997.
41. Tsunoda S, Salkoff L. Genetic analysis of Drosophila neurons: Shal, Shaw, and Shab encode most embryonic potassium currents. J Neurosci 15: 1741-1754, 1995.
42. + current in neurons cultured from neonatal rat hypothalamus and brain stem: modulation by angiotensin II. J Neurophysiol 78: 1021-1029, 1997.
43. Wang H, Huang BS, Ganten D, Leenen FH. Prevention of sympathetic and cardiac dysfunction after myocardial infarction in transgenic rats deficient in brain angiotensinogen. Circ Res 94: 843, 2004.
44. Wang W, Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev 5: 57-71, 2000.
45. Zhang TT, Cui B, Dai DZ. Downregulation of Kv4.2 and Kv4.3 channel gene expression in right ventricular hypertrophy induced by monocrotaline in rat. Acta Pharmacol Sin 25: 226-230, 2004.
46. Zhang TT, Takimoto K, Stewart AF, Zhu C, Levitan ES. Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine. Circ Res 88: 476-482, 2001.
47. Zhou C, Vignere CZ, Levitan ES. AUF1 is upregulated by angiotensin II to destabilize cardiac Kv4.3 channel. mRNA J Mol Cell Cardiol 45: 832-838, 2008.
48. Zhou C, Ziegler C, Birder LA, Stewart AF, Levitan ES. Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA. Circ Res 98: 1040-1047, 2006.
49. Zucker IH, Liu JL. Angiotensin II - nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail Rev 5: 27-43, 2000.